Literature DB >> 23579243

Molecular mechanisms of natural killer cell activation in response to cellular stress.

C J Chan1, M J Smyth, L Martinet.   

Abstract

Protection against cellular stress from various sources, such as nutritional, physical, pathogenic, or oncogenic, results in the induction of both intrinsic and extrinsic cellular protection mechanisms that collectively limit the damage these insults inflict on the host. The major extrinsic protection mechanism against cellular stress is the immune system. Indeed, it has been well described that cells that are stressed due to association with viral infection or early malignant transformation can be directly sensed by the immune system, particularly natural killer (NK) cells. Although the ability of NK cells to directly recognize and respond to stressed cells is well appreciated, the mechanisms and the breadth of cell-intrinsic responses that are intimately linked with their activation are only beginning to be uncovered. This review will provide a brief introduction to NK cells and the relevant receptors and ligands involved in direct responses to cellular stress. This will be followed by an in-depth discussion surrounding the various intrinsic responses to stress that can naturally engage NK cells, and how therapeutic agents may induce specific activation of NK cells and other innate immune cells by activating cellular responses to stress.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579243      PMCID: PMC3857624          DOI: 10.1038/cdd.2013.26

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  145 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

Review 2.  Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.

Authors:  Christopher J Chan; Daniel M Andrews; Mark J Smyth
Journal:  Curr Opin Immunol       Date:  2012-01-28       Impact factor: 7.486

3.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

4.  Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Authors:  Hai Li; Tadepally Lakshmikanth; Cinzia Garofalo; Martin Enge; Clemens Spinnler; Andrea Anichini; Laszlo Szekely; Klas Kärre; Ennio Carbone; Galina Selivanova
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

5.  Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Authors:  Cristina Cerboni; Alessandra Zingoni; Marco Cippitelli; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2007-04-03       Impact factor: 22.113

Review 6.  Manipulation of the host translation initiation complex eIF4F by DNA viruses.

Authors:  Derek Walsh
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 8.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Authors:  David H Raulet; Nadia Guerra
Journal:  Nat Rev Immunol       Date:  2009-08       Impact factor: 53.106

Review 9.  Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability.

Authors:  Patrizia Lavia; Anna Maria Mileo; Antonio Giordano; Marco G Paggi
Journal:  Oncogene       Date:  2003-09-29       Impact factor: 9.867

10.  Accelerated tumor growth in mice deficient in DNAM-1 receptor.

Authors:  Akiko Iguchi-Manaka; Hirayasu Kai; Yumi Yamashita; Kai Shibata; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Teruhito Yasui; Hitoshi Kikutani; Kazuko Shibuya; Akira Shibuya
Journal:  J Exp Med       Date:  2008-11-24       Impact factor: 14.307

View more
  63 in total

1.  In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Authors:  Kieran Seay; Candice Church; Jian Hua Zheng; Kathryn Deneroff; Christina Ochsenbauer; John C Kappes; Bai Liu; Emily K Jeng; Hing C Wong; Harris Goldstein
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Killing cancer cells, twice with one shot.

Authors:  M E Bianchi
Journal:  Cell Death Differ       Date:  2014-01       Impact factor: 15.828

3.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

4.  NK cells require IL-28R for optimal in vivo activity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Arabella Young; Deepak Mittal; Ludovic Martinet; Claudia Bruedigam; Kazuyoshi Takeda; Christopher E Andoniou; Mariapia A Degli-Esposti; Geoffrey R Hill; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-21       Impact factor: 11.205

Review 5.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

6.  Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Authors:  Corbin A Shields; Maggie McCalmon; Tarek Ibrahim; Dakota L White; Jan M Williams; Babbette LaMarca; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-02       Impact factor: 3.619

7.  Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

Authors:  Camille Guillerey; Lucas Ferrari de Andrade; Slavica Vuckovic; Kim Miles; Shin Foong Ngiow; Michelle C R Yong; Michele W L Teng; Marco Colonna; David S Ritchie; Marta Chesi; Martha Chesi; P Leif Bergsagel; Geoffrey R Hill; Mark J Smyth; Ludovic Martinet
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 8.  Combining epigenetic and immune therapy to overcome cancer resistance.

Authors:  Stephanie Gomez; Tomasz Tabernacki; Julie Kobyra; Paige Roberts; Katherine B Chiappinelli
Journal:  Semin Cancer Biol       Date:  2019-12-23       Impact factor: 15.707

9.  Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Authors:  Daniel Kerage; Megan S F Soon; Brianna L Doff; Takumi Kobayashi; Michael D Nissen; Pui Yeng Lam; Graham R Leggatt; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

10.  Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.

Authors:  Rikke Olesen; Selena Vigano; Thomas A Rasmussen; Ole S Søgaard; Zhengyu Ouyang; Maria Buzon; Arman Bashirova; Mary Carrington; Sarah Palmer; Christel R Brinkmann; Xu G Yu; Lars Østergaard; Martin Tolstrup; Mathias Lichterfeld
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.